Prostasomes as Diagnostic Tool for Prostate Cancer Detection | MicrobiomeTrials← Back to trialsNCT03694483
Prostasomes as Diagnostic Tool for Prostate Cancer Detection
SUSPENDEDOBSERVATIONAL
Trial Details
Start: 2018-10-03Est. Completion: 2026-10-01
Enrollment target: 600 participants Locations- Hackensack University Medical Center, Hackensack, New Jersey, United States
Other microbiome trials you might be interested in
Prostate CancerRecurrent Prostate CancerMetastatic Prostate CancerProstate Cancer RecurrentProstate Cancer Metastatic
This is a randomized, open-label, pilot study assessing the impact of a short course of bicalutamide on PSMA expression …
St Louis, United StatesEst. completion Nov 14, 2027
Recurrent Prostate CancerProstate Cancer
Background:
Biochemically recurrent prostate cancer (BCR) occurs when prostate-specific antigen (PSA) levels in the blo…
Bethesda, United StatesEst. completion Jan 30, 2029